Related Experiment Video
Updated: Mar 5, 2026

Real-Time Monitoring and Modulation of Blood Pressure in a Rabbit Model of Ischemic Stroke
Published on: February 10, 2023
Hemodynamic responses to magnetic stimulation of carotid sinus in normotensive rabbits
Jun Zhang1, Qinqin Cao, Rongrong Li
1aDepartment of Neurology, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu bDepartment of Neurology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong cDepartment of Neurology, Jinling Hospital, Second Military Medical University, Nanjing, Jiangsu, China *Jun Zhang and Qinqin Cao contributed equally to the article.
Objectives:
Carotid baroreflex plays a crucial role in regulating arterial pressure. Based on this knowledge, electrical stimulation of carotid sinus was designed for treating resistant hypertension. However, the clinical implication of electrical stimulation of carotid sinus is largely restrained due to obvious invasiveness. This study aimed to evaluate the efficacy of magnetic stimulation of carotid sinus (MSCS), a noninvasive strategy, for lowering blood pressure in rabbits.
Methods:
MSCS with graded intensities and frequencies were systematically attempted in normotensive rabbits. Blood pressure was recorded dynamically. Sinoaortic denervation and plasma hormone level analyses were performed.
Results:
When the right carotid sinus was stimulated at 1 Hz frequency, a dose-effect relationship was observed between stimulation intensity (100-250% motor threshold) and mean arterial pressure (MAP) decrement (3.6 ± 1.0 to 10.4 ± 2.3 mmHg). When stimulation intensity was fixed at 200% motor threshold, the median reduction of MAP in 1-Hz group [10.8 (8.6-14.9) mmHg] was significantly higher than that in other frequency groups (all P < 0.05). Heart rates declined transiently after the initiation of MSCS. Compared with baseline (33.9 ± 5.5 pg/ml), plasma epinephrine level increased during MSCS (88.1 ± 9.6, P = 0.002). After ipsilateral sinoaortic denervation, MAP decrement (7.0 ± 0.8 mmHg) was remarkably blunted compared with that in sham animals (13.0 ± 1.1 mmHg, P = 0.001).
Conclusion:
The current study demonstrated that MSCS treatment can lower the arterial pressure in normotensive rabbits. This preliminarily result warrants further studies to establish the efficacy of MSCS in treating refractory hypertension.

